← Leaderboards
Mary Jane Thomassen
Cleveland Clinic Foundation
$4,484,343
Attributed
$4,484,343
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $499K · FY2005–20$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,484,343 · 5
By mechanism
R01$3,710,964 · 3
R21$405,220 · 1
R15$368,159 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Tracey L Bonfield$2,183,187
Others in their field
Top investigators on “Colony Stimulating Factor”
- E Richard Stanley · Yeshiva University$18,630,085
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Bruce C Trapnell · Children'S Hospital Med Ctr (Cincinnati)$15,276,560
- David Chandler Dale · University Of Washington$13,463,471
- George S. Deepe · University Of Cincinnati$12,708,900
- Jay K Kolls · Tulane University Of Louisiana$12,370,057
Research focus
Colony Stimulating FactorInterleukin 10Clinical ResearchPhenotypePulmonary Alveolar ProteinosisB LymphocyteCytokineHuman SubjectLinkLung DiseasesSarcoidosisTranscription FactorLungAutoantibodyInflammationPpar GammaFunctional DisorderGenetic PolymorphismCellsAntibody FormationCholesterol TransportersAtp-Binding Cassette TransportersBronchoalveolar LavageAtp Binding Cassette Transporter 1
Grant awards (16)
Alveolar Macrophages in Granulomatous Disease$311,261
R01 · FY2020 · ES · contact PI
Alveolar Macrophages in Granulomatous Disease$311,326
R01 · FY2019 · ES · contact PI
Alveolar Macrophages in Granulomatous Disease$311,386
R01 · FY2018 · ES · contact PI
Alveolar Macrophages in Granulomatous Disease$314,183
R01 · FY2017 · ES · contact PI
Alveolar Macrophages in Granulomatous Disease$314,824
R01 · FY2016 · ES · contact PI
Chronic Granulomatous Lung Inflammation Elicited by Carbon Nanotubes$368,159
R15 · FY2013 · ES · contact PI
Cytokine Dysregulation in GM-CSF Autoimmunity$270,231
R01 · FY2007 · AI · contact PI
Cytokine Dysregulation in GM-CSF Autoimmunity$278,303
R01 · FY2006 · AI · contact PI
Cytokine Dysregulation in GM-CSF Autoimmunity$285,000
R01 · FY2005 · AI
PPARgamma Dysfunction in Sarcoidois$210,766
R21 · FY2005 · HL
PPARgamma Dysfunction in Sarcoidois$3,204
R21 · FY2005 · HL
PPARgamma Dysfunction in Sarcoidois$191,250
R21 · FY2004 · HL
GM-CSF THERAPY FOR ALVEOLAR PROTEINOSIS$344,250
R01 · FY2003 · HL
GM-CSF THERAPY FOR ALVEOLAR PROTEINOSIS$321,000
R01 · FY2002 · HL
GM-CSF THERAPY FOR ALVEOLAR PROTEINOSIS$321,000
R01 · FY2001 · HL
GM-CSF THERAPY FOR ALVEOLAR PROTEINOSIS$328,200
R01 · FY2000 · HL